This inventor holds 1 USPTO granted patent. Top assignee: Kunming University of Science and Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Shaoxing Dai in Antiviral Drug Development
Introduction
Shaoxing Dai is a notable inventor based in Kunming, China. He has made significant contributions to the field of antiviral drug development. His innovative work focuses on the creation of a sesquiterpenoid derivative that has the potential to combat various viral infections.
Latest Patents
Shaoxing Dai holds a patent for a sesquiterpenoid derivative and its use in preparing a broad-spectrum antiviral drug. This invention can stimulate heterogeneous nuclear ribonucleoprotein A2/B1, activate the cell signal pathway of TANK-binding kinase 1-interferon regulatory factor 3, and increase the expression and secretion of endogenous type I interferon. As a result, it can inhibit various viruses and can be used as a broad-spectrum antiviral drug for preventing or treating various viral infectious diseases and symptoms, including Covid-19, vesicular stomatitis virus, AIDS virus, hepatitis C virus, Japanese encephalitis virus, influenza virus, poliovirus, Coxsackie virus, dengue virus, rotavirus, tobacco mosaic virus, measles virus, mumps virus, Ebola virus, Marburg virus, herpes virus, and adenovirus. The sesquiterpenoid derivatives can be formulated into oral dosage forms such as tablets, capsules, and dripping pills, or clinically acceptable pharmaceutical preparations such as inhalants and injections.
Career Highlights
Shaoxing Dai is affiliated with Kunming University of Science and Technology, where he conducts his research and development activities. His work has garnered attention for its potential impact on public health, particularly in the context of emerging viral threats.
Collaborations
Shaoxing Dai collaborates with Min Xu, who is also involved in research related to antiviral drugs. Their partnership enhances the scope and depth of their innovative projects.
Conclusion
Shaoxing Dai's contributions to antiviral drug development through his patented sesquiterpenoid derivative highlight the importance of innovation in addressing global health challenges. His work exemplifies the potential of scientific research to create effective solutions for viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile